Obesity increases the risk for venous thromboembolism (VTE), but whether high-dose
thromboprophylaxis is safe and effective in morbidly obese inpatients is unknown. It was the …

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in
hospitalized patients. Where appropriate, evidence-based methods of prophylaxis are …

INTRODUCTION: In clinical trials, fixed-dose enoxaparin (40 mg once daily) reduces the risk
of venous thromboembolism (VTE) in medically-ill patients. However, morbidly obese …

Pharmacologic prophylaxis of deep vein thrombosis and venous thromboembolism (VTE) is
an important aspect of medical care, particularly in the inpatient setting. Low-molecular …

Thromboprophylaxis is a mainstay of hospital care in patients at high risk of thrombosis.
Fixed doses of low-molecular-weight heparin (LMWH) are recommended for …

Background: Obesity is considered a highly prevalent risk factor for venous
thromboembolism (VTE) in hospitalized patients. However, recommendations for VTE …

Objective: To review the literature on both thromboprophylaxis and treatment of venous
thromboembolism (VTE) with enoxaparin in low-and high-body-weight patients and to make …

Background: Obese patients undergoing bariatric surgery are at significant risk for venous
thromboembolism (VTE). We performed a multicenter, retrospective survey to evaluate the …

Background The bariatric surgical population is a particularly high risk population for VTE. It
is unclear if standard (ie non-adjusted) thromboprophylaxis doses of low-molecular weight …

Venous thromboembolism (VTE) is a major health concern associated with significant
morbidity and mortality. Critically ill patients are at an increased risk of VTE compared to …